Related content

Lymphocyte recovery on day 100 after allogeneic hematopoietic stem cell transplant predicts non-relapse mortality in patients with acute leukemia or myelodysplastic syndrome

By Yamamoto Wataru   Ogusa Eriko   Matsumoto Kenji   Maruta Atsuo   Ishigatsubo Yoshiaki   Kanamori Heiwa  

Leukemia and Lymphoma, Vol. 55, Iss. 5, 2014-05 ,pp. : 1113-1118

Informa Healthcare

Access to resources Recommend Favorite

Multicenter validation of scoring system of pre-transplant serum ferritin and disease risk in patients with acute myeloid leukemia and myelodysplastic syndrome after allogeneic hematopoietic stem cell transplant

By Tachibana Takayoshi  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1318-1320

Informa Healthcare

Access to resources Recommend Favorite

Survival and prognostic factors of allogeneic hematopoietic stem cell transplant recipients admitted to intensive care unit

By Moreau Anne-Sophie   Seguin Amélie   Lemiale Virginie   Yakoub-Agha Ibrahim   Girardie Patrick   Robriquet Laurent   Mangalaboyi Jacques   Fourrier François   Jourdain Mercé  

Leukemia and Lymphoma, Vol. 55, Iss. 6, 2014-06 ,pp. : 1417-1420

Informa Healthcare

Access to resources Recommend Favorite

Outcome of relapse after allogeneic stem cell transplant in patients with acute myeloid leukemia

By Devillier Raynier   Crocchiolo Roberto   Etienne Anne   Prebet Thomas   Charbonnier Aude   Fürst Sabine   El-Cheikh Jean   D'Incan Evelyne   Rey Jérôme   Faucher Catherine   Blaise Didier   Vey Norbert  

Leukemia and Lymphoma, Vol. 54, Iss. 6, 2013-06 ,pp. : 1228-1234

Informa Healthcare

Access to resources Recommend Favorite

The symptom experience in the first 100 days following allogeneic hematopoietic stem cell transplantation (HSCT)

By Bevans Margaret  

Supportive Care in Cancer, Vol. 16, Iss. 11, 2008-11 ,pp. : 1243-1254

Springer Publishing Company

Access to resources Recommend Favorite